Journal of Jilin University(Medicine Edition) ›› 2025, Vol. 51 ›› Issue (5): 1260-1266.doi: 10.13481/j.1671-587X.20250512
• Research in basic medicine • Previous Articles Next Articles
Han XUE1,Yuxin FAN1,Ting ZHANG2,Zhimin LI1,Mingge HUO1,Xingang GUAN1,3(
)
Received:2024-10-19
Accepted:2024-12-05
Online:2025-09-28
Published:2025-11-05
Contact:
Xingang GUAN
E-mail:guanxg@ciac.ac.cn
CLC Number:
Han XUE,Yuxin FAN,Ting ZHANG,Zhimin LI,Mingge HUO,Xingang GUAN. Preparation of nanodrug PTX2 NPs and its killing effect on human lung cancer A549 cells[J].Journal of Jilin University(Medicine Edition), 2025, 51(5): 1260-1266.
| [1] | KLEIN I, LEHMANN H C. Pathomechanisms of paclitaxel-induced peripheral neuropathy[J]. Toxics, 2021, 9(10): 229. |
| [2] | ZHAO S, TANG Y F, WANG R H, et al. Mechanisms of cancer cell death induction by paclitaxel: an updated review[J]. Apoptosis, 2022, 27(9/10): 647-667. |
| [3] | YANG Y H, MAO J W, TAN X L. Research progress on the source, production, and anti-cancer mechanisms of paclitaxel[J]. Chin J Nat Med, 2020, 18(12): 890-897. |
| [4] | 黄佳欢, 雷 蕾, 王晓稼. 白蛋白结合型紫杉醇治疗晚期乳腺癌的研究进展[J]. 实用肿瘤杂志, 2021, 36(6): 496-501. |
| [5] | SANTOS FARIA R, DE LIMA L I, BONADIO R S, et al. Liposomal paclitaxel induces apoptosis, cell death, inhibition of migration capacity and antitumoral activity in ovarian cancer[J]. Biomed Pharmacother, 2021, 142: 112000. |
| [6] | ASHRAFIZADEH M, MIRZAEI S, HASHEMI F, et al. New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities[J]. Biomed Pharmacother, 2021, 141: 111824. |
| [7] | HAIDER M, JAGAL J, BAJBOUJ K, et al. Integrated multi-omics analysis reveals unique signatures of paclitaxel-loaded poly(lactide-co-glycolide) nanoparticles treatment of head and neck cancer cells[J]. Proteomics, 2023, 23(16): e2200380. |
| [8] | 马晶晶, 杨 政, 郭 惠, 等. 水溶性及靶向性紫杉醇前药的研究进展[J]. 中国新药杂志, 2021, 30(16): 1489-1497. |
| [9] | MENG Z Y, LV Q X, LU J, et al. Prodrug strategies for paclitaxel[J]. Int J Mol Sci, 2016, 17(5): 796. |
| [10] | 吴 莉, 郑桐森. 白蛋白结合型紫杉醇联合替吉奥治疗晚期胰腺癌的研究进展[J]. 现代肿瘤医学, 2022, 30(9): 1706-1709. |
| [11] | ALAVI M, NOKHODCHI A. Micro- and nanoformulations of paclitaxel based on micelles, liposomes, cubosomes, and lipid nanoparticles: Recent advances and challenges[J]. Drug Discov Today, 2022, 27(2): 576-584. |
| [12] | GAO Y, NAI J X, YANG Z B, et al. A novel preparative method for nanoparticle albumin-bound paclitaxel with high drug loading and its evaluation both in vitro and in vivo [J]. PLoS One, 2021, 16(4): e0250670. |
| [13] | 张思楠, 张丽娜. 紫杉醇的研究进展[J]. 山东化工, 2023, 52(9): 72-74. |
| [14] | SUN L L, ZHAO P, CHEN M H, et al. Taxanes prodrug-based nanomedicines for cancer therapy[J]. J Control Release, 2022, 348: 672-691. |
| [15] | INGLE S G, PAI R V, MONPARA J D, et al. Liposils: an effective strategy for stabilizing Paclitaxel loaded liposomes by surface coating with silica[J]. Eur J Pharm Sci, 2018, 122: 51-63. |
| [16] | TIAN Z C, YAO W T. Albumin-bound paclitaxel: worthy of further study in sarcomas[J]. Front Oncol, 2022, 12: 815900. |
| [17] | 王 健, 裴 晴, 谢志刚. 紫杉醇二聚体纳米前药研究进展[J]. 化学研究, 2021, 32(4): 283-289, 337. |
| [18] | 裴 晴. 具有超高载药量的紫杉醇二聚体纳米前药用于肿瘤治疗[D]. 合肥: 中国科学技术大学, 2019. |
| [19] | 姚秀敏, 郝登远, 裴 晴, 等. 基于磷脂基紫杉醇纳米前药的抗肿瘤应用研究[J]. 高分子学报, 2023, 54(5): 708-719. |
| [20] | 郭苗苗. LND-SS-GEM/DSPE-PEG-FA纳米前药的制备及抗H460肺癌细胞作用机制研究[D]. 长春: 吉林大学, 2024. |
| [21] | 周 洁, 郑燕婷, 江舒琪, 等. CT影像组学联合形态学特征模型评估非小细胞肺癌患者预后生存期的价值[J]. 中国医学物理学杂志, 2024, 41(1): 18-26. |
| [22] | 邱丽亮, 程玖玲, 王华启. NSCLC患者免疫检查点抑制剂相关性肺炎临床特点及其危险因素分析[J]. 解放军医学杂志, 2024, 49(8): 861-867. |
| [23] | 黄莉莉, 刘宇轩, 方楷漪, 等. 载奥沙利铂细胞膜囊泡纳米药物的制备及其对小鼠结肠癌细胞的杀伤作用[J]. 吉林大学学报(医学版), 2021, 47(6): 1422-1428. |
| [24] | WANG D D, WANG Y T, ZHAO G C, et al. Improving systemic circulation of paclitaxel nanocrystals by surface hybridization of DSPE-PEG2000[J]. Colloids Surf B Biointerfaces, 2019, 182: 110337. |
| [25] | 陈聪慧, 刘孟瑜. 靶向及pH敏感仿脂蛋白结构纳米载体运载紫杉醇的体内抗肿瘤研究[J]. 中国中药杂志, 2019, 44(10): 2072-2077. |
| [26] | ZHANG Z R, WANG X Y, LI B B, et al. Paclitaxel-loaded PLGA microspheres with a novel morphology to facilitate drug delivery and antitumor efficiency[J]. RSC Adv, 2018, 8(6): 3274-3285. |
| [1] | Yang LI,Shiyang LI,Hongmei ZHANG,Qianqian LIU,Yubing CHEN. Effect of NGFR gene expression differences on promotion of apoptosis of squamous cell carcinoma and adenocarcinoma cells by PD-1 inhibitor-activated T lymphocytes [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 680-693. |
| [2] | Qiaotong REN,Weihua WU,Xingxiang WANG,Shichao WANG,Yipeng CHENG,Chun LI. Effect of interleukin-17 recepter B gene silencing on proliferation, invasion and apoptosis of lung adenocarcinoma A549 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 738-745. |
| [3] | Qiuping SU,Lei XING,Wei ZHANG,Shan JIANG,Yangyang ZHAO,Fangfang CHEN. Research progress in anti-tumor mechanism of berberine and application of its novel nano-delivery system in tumor therapy [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 863-871. |
| [4] | Jie YU,Zongkang WANG,Xun LIU,Yanan YANG,Jin TAN. Effect of miR-153-3p/PGC-1α axis on apoptosis of oral squamous cell carcinoma cells by modulation of mitochondrial apoptosis pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 348-358. |
| [5] | Tian LI,Jiafeng WANG,Zhimin ZHANG. Research progress in application of exosomes in diagnosis and treatment of oral diseases [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 543-550. |
| [6] | Yaping LI,Chunyan TAN,Lujie ZHAO,Jiayi ZHAO,Ting LI,Xiao YANG,Xiaoyun YANG. Inductive effect of lysophosphatidic acid combined with 6-hydroxydopamine on apoptosis of SH-SY5Y cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 152-161. |
| [7] | Jiaxin WANG,Junwen MAO,Xuan ZHANG. Expression of natural autoantibodies against apoptosis inhibitory genes in plasma of patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 228-235. |
| [8] | Huaimin LIANG,Jiacheng JIN,Wenhua CHEN,Yuyao LI,Hangyu WANG,Ke ZHANG,Jinhui WANG. UPLC-Q-TOF/MS and network pharmacology analysis and experimental verification based on potential active ingredients and mechanisms of medicinal Mulberry Leaves in anti-acute kidney injury [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 56-69. |
| [9] | Shanshan SUN,Mei LU,Xinfu GAO,LYu Guangyao,Baolei Zhao,LYu Wenwen. Inhibitory effect of Bradykinin 1 receptor antagonist ELN441958 on proliferation of HepG2 cells by regulating Akt/FoxO3a signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 70-80. |
| [10] | Xiaohan YAO,Mingchen YAO,Zhiqing WANG,Heyang LI,Yan YAN,Ningjing LEI. Effect of silencing GPR139 gene on proliferation, apoptosis and autophagy of breast cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 1-9. |
| [11] | Jiarui LI,Zhenlin YANG,Fan GAO,Jingjing GUO,Jinzi LI. Effect of miR-34a-5p on hippocampal neuron apoptosis in rats with temporal lobe epilepsy and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 939-947. |
| [12] | Panxi SUN,Xue QIN,Chongyang ZHANG,Jia LUO,Yong CHEN,Lili WEI. Protective effect of TUG-891 on ischemic stroke induced by ischemia and hypoxia and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 968-975. |
| [13] | Cheng CHEN,Jingyao LI,Wanxiang HU,Donghui LIU,Zhihong CHEN. Protective effect of sericin on streptozotocin-induced INS-1 cell damage by regulating PI3K/Akt/NF-κB signaling pathway through Akt1 and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 590-598. |
| [14] | Donghui LIU,Yunzhe CI,Chunyan WANG,Wenyi MA. Effect of miR-199a-5p on expression of Caveolin-1, cell migration and apoptosis in glioma U251 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 663-671. |
| [15] | Fan WANG,Xin WEN,Yixuan WANG,Yuan WANG. Effect of gap junction β2 on prognosis of patients with lung adenocarcinoma and biological behavior of lung adenocarcinoma A549 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 716-726. |